Suchergebnisse - "Taub, Jeffrey W"

PubPharm (11)

1

Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo

enthalten in: Biochemical pharmacology | 2018

von Su, Y. | Li, X. | Ma, J. | +7

2

Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer

enthalten in: Oncotarget | 2017

von Ning, C. | Liang, M. | Liu, S. | +10

3

Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells

enthalten in: Scientific reports | 2017

von Ma, J. | Li, X. | Su, Y. | +11

4

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells

enthalten in: Oncotarget | 2017

von Zhao, J. | Xie, C. | Edwards, H. | +3

5

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

enthalten in: Oncotarget | 2016

von Zhao, J. | Niu, X. | Li, X. | +6

6

Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo

enthalten in: Cancer biology & therapy | 2015

von Qi, W. | Zhang, W. | Edwards, H. | +8

7

CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells

enthalten in: Journal of hematology & oncology | 2014

von Qi, W. | Xie, C. | Li, C. | +6

8

Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells

enthalten in: The Journal of biological chemistry | 2013

von Hales, E. | Orr, S. | Larson Gedman, A. | +2

9

Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells

enthalten in: PloS one | 2013

von Wang, G. | Edwards, H. | Caldwell, J. | +5

10

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51

enthalten in: PloS one | 2013

von Xie, C. | Drenberg, C. | Edwards, H. | +8